Personalized mRNA cancer vaccines with immune checkpoint inhibitors: A promising therapeutic approach in oral cancer patients

被引：3
|
作者：
Gheena, Sukumaran [1 ]
Ezhilarasan, Devaraj [2 ]
机构：
[1] Saveetha Inst Med & Tech Sci SIMATS, Saveetha Dent Coll, Dept Oral Pathol, Chennai 600077, Tamil Nadu, India
[2] Saveetha Inst Med & Tech Sci SIMATS, Saveetha Dent Coll, Dept Pharmacol, Mol Med & Toxicol Lab, 162 PH Rd, Chennai 600077, Tamil Nadu, India
来源：
ORAL ONCOLOGY | 2023年 / 137卷
关键词：
D O I：
10.1016/j.oraloncology.2022.106282
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Vaccines and immune checkpoint inhibitors: a promising combination strategy in gastrointestinal cancers
    Bashir, Babar
    Flickinger, John C.
    Snook, Adam E.
    IMMUNOTHERAPY, 2021, 13 (07) : 561 - 564
  • [22] Immunotherapy with checkpoint inhibitors in patients with ovarian cancer: Still promising?
    Gonzalez-Martin, Antonio
    Sanchez-Lorenzo, Luisa
    CANCER, 2019, 125 : 4616 - 4622
  • [23] Clinical Characteristics and Outcomes of Oral Mucositis Associated With Immune Checkpoint Inhibitors in Patients With Cancer
    Jacob, Jake S.
    Dutra, Barbara E.
    Garcia-Rodriguez, Victor
    Panneerselvam, Kavea
    Abraham, Fiyinfoluwa O.
    Zou, Fangwen
    Ma, Weijie
    Grivas, Petros
    Thompson, John A.
    Altan, Mehmet
    Oliva, Isabella C. Glitza
    Zhang, Hao Chi
    Thomas, Anusha S.
    Wang, Yinghong
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (12): : 1415 - +
  • [24] Clinical Characteristics and Outcome of Oral Mucositis Associated With Immune Checkpoint Inhibitors in Patients With Cancer
    Jacob, Jake
    Dutra, Barbara E.
    Garcia-Rodriguez, Victor
    Panneerselvam, Kavea
    Abraham, Fiyinfoluwa O.
    Zou, Fangwen
    Grivas, Petros
    Thompson, John
    Thomas, Anusha Shirwaikar
    Wang, Yinghong
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S186 - S186
  • [25] Cancer vaccines at the age of immune checkpoint inhibitors: reasonable approach as combination therapy in advanced urothelial carcinoma?
    Grivas, P.
    Koshkin, V. S.
    Pal, S. K.
    ANNALS OF ONCOLOGY, 2017, 28 (04) : 680 - 682
  • [26] Cancer cachexia reduces the efficacy of immune checkpoint inhibitors in cancer patients
    Yu, Yean
    Yan, Li
    Huang, Tianhui
    Wu, Zhenfu
    Liu, Juan
    AGING-US, 2024, 16 (06): : 5354 - 5369
  • [27] Neurologic complications of immune checkpoint inhibitors in cancer patients
    Youssef, Michael
    Woodman, Karin
    NEUROLOGY, 2018, 90
  • [28] Cardiotoxicity of Immune Checkpoint Inhibitors in Patients with Lung Cancer
    Chitturi, Kalyan R.
    Araujo-Gutierrez, Raquel
    McLean, Edward T.
    Xu, Jiaqiong
    Bhimaraj, Arvind
    Guha, Ashrith
    Hussain, Imad
    Trachtenberg, Barry H.
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S50 - S50
  • [29] Hyperprogression in Patients With Cancer Receiving Immune Checkpoint Inhibitors
    Sehgal, Kartik
    JAMA NETWORK OPEN, 2021, 4 (03)
  • [30] The efficacy of immune checkpoint inhibitors in patients with cancer with pseudoprogression
    Lyadova, Marina
    Fedorinov, Denis
    Pardabekova, Olesya
    Nosova, Margarita
    Tuleiko, Veronika
    Lyadov, Vladimir
    Kuzmina, Evgenia
    Antonova, Tatiana
    Lyadov, Konstantin
    Galkin, Vsevolod
    Poddubnaya, Irina
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345